불임 및 임신 신속 검사 키트 시장 평가 : 제품별, 검사 유형별, 유통 채널별, 지역별 기회 및 예측(2017-2031년)

Global fertility and pregnancy rapid kits market is projected to witness a CAGR of 6.18% during the forecast period 2024-2031, growing from USD 1.68 billion in 2023 to USD 2.71 billion in 2031. The market for fertility and pregnancy rapid kits is growing at a consistent pace owing to the rising awareness about reproductive health, easy availability of kits through e-commerce platforms, rising cases of infertility, and innovative product launches around this space.

Fertility and pregnancy rapid kits detect the hormone levels in the body of females, which is a major determinant of pregnancy and fertility in women. They offer a convenient, at-home solution for early pregnancy detection, typically providing results within minutes. The market of these kits is registering significant growth opportunities owing to the shifting paradigm of sexual expression, rising awareness about reproductive health, and great emphasis on the conception of the planned children. The OTC designation of these products adds significant expansion of market share owing to improved accessibility and availability. Booming e-commerce and quick commerce platforms further improve accessibility while keeping the purchase discreet to maintain the dignity of the buyer. Furthermore, new product launches and campaigns being run by market players and other stakeholders give a push to the market. For instance, in June 2024, Prega News, a pregnancy detection card by Mankind Pharma Ltd., launched its expert pregnancy care solution range in collaboration with its brand ambassador, targeting the southern Indian market. The initiative aims to increase brand presence and provide essential products for pregnancy. The launch featured over 70 mom influencers, further expanding the brand's reach in key regional markets like Karnataka and Chennai, India.

Growing Awareness About Reproductive Health Drives the Market

The growing awareness of reproductive health significantly boosts the market for fertility and pregnancy rapid kits. As people are becoming increasingly aware of not only their reproductive health but also taking proactive steps to handle those health aspects, the demand for quick at-home testing solutions has increased considerably. Increased education on fertility issues, along with changes in trends toward proactive health management, compel consumers towards early detection tools. Besides this, the social stigma associated with infertility and reproductive health issues is slowly fading away, and thus, more are searching for help and guidance. Technological innovations have even made these kits more convenient and accurate. This makes them very accessible. Campaigns for health and grassroots organizations in place also add to creating awareness and a friendly atmosphere around people looking to conceive. This combined factor places the fertility and pregnancy rapid kits market on a stable growth trajectory as awareness remains on an expansion course. For instance, in February 2023, Action Canada for Sexual Health & Rights ran a signature public health campaign during Sexual Health Week, raising awareness on key issues in sexual health, education, and healthcare.

Easy Availability of Kits Through E-Commerce Platforms Drives Market Growth

Easy accessibility of fertility and pregnancy rapid kits through e-commerce is one of the factors driving market growth. Online retailers can offer consumers ease of accessing a huge variety of products without the complications of traditional brick-and-mortar stores. Access is particularly imperative for sensitive health buyers since it provides users with an alternative to shopping discreetly from their homes. Competitive pricing and consumer reviews enable the customer to make the best decision on an e-commerce platform. Fast shipping options and consumer eligibility to join an order subscription plan make online shopping, in this case, more likely to lead to repeat business. Additionally, targeted advertising online and opportunities for education about reproductive health add to the momentum of knowing, seeing, and acting upon these needs. The convenience and privacy offered by e-commerce gives an impetus to sales and promote a more proactive approach to reproductive health, thereby augmenting the growth in the fertility and pregnancy rapid kits market. For instance, in October 2024, Amazon Pharmacy (Amazon.com Services LLC) announced plans to open pharmacies in 20 new cities across the United States in 2025. This expansion will double the number of cities where customers can receive Same-Day Delivery for their medications, including pregnancy test kits. Amazon is utilizing its extensive logistics network and advanced automation technology to address one of the pharmacy industry's biggest challenges: the lack of convenient and affordable access to medications.

Dominance of Pregnancy Rapid Test Kits Segment in Market

Pregnancy rapid test kits are more commonly used than fertility rapid kits for several reasons. First, they address an immediate need for pregnancy confirmation, appealing to many individuals and couples trying to conceive. Their simplicity and ease of use, requiring only a urine sample for quick results, increase their popularity. Pregnancy tests are widely available in pharmacies and online, making them easily accessible, while fertility kits are familiar and not as readily found. These factors contribute to the higher usage of pregnancy rapid test kits. Additionally, frequent product launches of pregnancy rapid kits further strengthen the market share of this segment. In October 2024, First Response (Church & Dwight Co., Inc.) launched the Multi Check Pregnancy Test Kit, featuring the innovative EasyCup, designed to simplify pregnancy testing. This kit includes an all-in-one sample collection cup and two Rapid Result tests, catering to consumer preferences for cleanliness and ease. A study revealed that 46% of users prefer using a cup for testing. The Multi Check Kit aims to provide convenience and support for individuals on their reproductive journeys, reinforcing First Response's commitment to user-friendly solutions in pregnancy testing.

North America Dominates the Fertility and Pregnancy Rapid Kits Market

North America dominates the fertility and pregnancy rapid kits market because of several key factors. First, increasing consumer awareness and focusing on sexual health drive demand for these products. Most people and couples are seeking solutions with ease that allow for early detection of pregnancy and tracking of fertility. Easy access to advanced health facilities and technology in North America also makes a play. The region enjoys the development of new products with a higher degree of accuracy and ease of use in the kits used for testing. On top of such marketing and educational initiatives, awareness and acceptance of these kits further improves. The presence of established manufacturers and an extensive distribution network positively impacts the availability of these products, particularly in sales through e-commerce platforms. Furthermore, cultural factors promoting proactive health management result in a greater willingness to invest in fertility and pregnancy testing. Collectively, all these factors place North America in a very favorable position as a market for fertility and pregnancy rapid kits.

Future Market Scenario (2024-2031F)

The emergence of recyclable pregnancy kits is poised to transform the market landscape significantly. Companies like OVUM have launched fully recyclable tests, addressing the environmental impact of traditional single-use kits, which contribute millions of pounds of plastic waste annually. These innovations reduce landfill contributions and offer cost savings for consumers over time, as reusable options eliminate the need for repeated purchases. As consumer awareness of sustainability grows, the demand for eco-friendly products in reproductive health is expected to rise, encouraging more brands to adopt similar practices. This shift promotes environmental responsibility and aligns with broader healthcare trends toward sustainability, ultimately setting new standards in the pregnancy testing market.

Key Players Landscape and Outlook

The fertility and pregnancy kits market is fragmented and distributed among a huge number of market players with intense market competition as the products overlap with the healthcare and FMCG sectors. The market has witnessed several innovative product launches, technological advances, acquisitions, and other types of business deals in recent years.

In August 2024, LetsGetChecked, Inc., an Irish health testing startup, is set to acquire United States' digital pharmacy Truepill Inc. for USD 525 million, which includes a focus on expanding its range of at-home testing kits, particularly in fertility. Founded in 2015, LetsGetChecked offers hormone and fertility tests, among other health diagnostics. The acquisition will be financed through a USD 150 million convertible note offering. This merger aims to improve capabilities in health tech, emphasizing their commitment to innovative healthcare solutions.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Fertility and Pregnancy Rapid Kits Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product
    • 4.2.1.1. Pregnancy Rapid Tests
      • 4.2.1.1.1. Line Indicator devices
        • 4.2.1.1.1.1. Strips/Dip Sticks
        • 4.2.1.1.1.2. Mid-Stream
        • 4.2.1.1.1.3. Cassettes
      • 4.2.1.1.2. Digital
    • 4.2.1.2. Fertility Rapid Tests
      • 4.2.1.2.1. Line Indicator
      • 4.2.1.2.2. Digital
  • 4.2.2. By Test Type
    • 4.2.2.1. LH Urine
    • 4.2.2.2. FSH Urine
    • 4.2.2.3. hCG Blood
    • 4.2.2.4. hCG Urine
  • 4.2.3. By Distribution Channel
    • 4.2.3.1. Pharmacies
    • 4.2.3.2. Gynecology/Fertility Clinics
    • 4.2.3.3. E-Commerce
    • 4.2.3.4. Hypermarkets and Supermarkets
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Product
  • 4.3.2. By Test Type
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Region

5. North America Fertility and Pregnancy Rapid Kits Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Product
    • 5.2.1.1. Pregnancy Rapid Tests
      • 5.2.1.1.1. Line Indicator devices
        • 5.2.1.1.1.1. Strips/Dip Sticks
        • 5.2.1.1.1.2. Mid-Stream
        • 5.2.1.1.1.3. Cassettes
      • 5.2.1.1.2. Digital
    • 5.2.1.2. Fertility Rapid Tests
      • 5.2.1.2.1. Line Indicator
      • 5.2.1.2.2. Digital
  • 5.2.2. By Test Type
    • 5.2.2.1. LH Urine
    • 5.2.2.2. FSH Urine
    • 5.2.2.3. hCG Blood
    • 5.2.2.4. hCG Urine
  • 5.2.3. By Distribution Channel
    • 5.2.3.1. Pharmacies
    • 5.2.3.2. Gynecology/Fertility Clinics
    • 5.2.3.3. E-Commerce
    • 5.2.3.4. Hypermarkets and Supermarkets
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States Fertility and Pregnancy Rapid Kits Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Product
        • 5.3.1.2.1.1. Pregnancy Rapid Tests
        • 5.3.1.2.1.1.1. Line Indicator devices
        • 5.3.1.2.1.1.1.1. Strips/Dip Sticks
        • 5.3.1.2.1.1.1.2. Mid-Stream
        • 5.3.1.2.1.1.1.3. Cassettes
        • 5.3.1.2.1.1.2. Digital
        • 5.3.1.2.1.2. Fertility Rapid Tests
        • 5.3.1.2.1.2.1. Line Indicator
        • 5.3.1.2.1.2.2. Digital
      • 5.3.1.2.2. By Test Type
        • 5.3.1.2.2.1. LH Urine
        • 5.3.1.2.2.2. FSH Urine
        • 5.3.1.2.2.3. hCG Blood
        • 5.3.1.2.2.4. hCG Urine
      • 5.3.1.2.3. By Distribution Channel
        • 5.3.1.2.3.1. Pharmacies
        • 5.3.1.2.3.2. Gynecology/Fertility Clinics
        • 5.3.1.2.3.3. E-Commerce
        • 5.3.1.2.3.4. Hypermarkets and Supermarkets
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Fertility and Pregnancy Rapid Kits Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Poland

7. Asia-Pacific Fertility and Pregnancy Rapid Kits Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America Fertility and Pregnancy Rapid Kits Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa Fertility and Pregnancy Rapid Kits Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa
• 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

• 16.1. Market Drivers
• 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

• 18.1. Regulatory Approvals
• 18.2. Innovations

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

• 21.1. Competition Matrix of Top 5 Market Leaders
• 21.2. SWOT Analysis for Top 5 Players
• 21.3. Key Players Landscape for Top 10 Market Players
  • 21.3.1. Alere Inc.
    • 21.3.1.1. Company Details
    • 21.3.1.2. Key Management Personnel
    • 21.3.1.3. Products and Services
    • 21.3.1.4. Financials (As Reported)
    • 21.3.1.5. Key Market Focus and Geographical Presence
    • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 21.3.2. Quidel Corporation
  • 21.3.3. Prestige Brands Holdings, Inc.
  • 21.3.4. Church & Dwight Co., Inc.
  • 21.3.5. bioMerieux SA
  • 21.3.6. Geratherm Medical AG
  • 21.3.7. Abbott Laboratories
  • 21.3.8. Procter & Gamble Co.
  • 21.3.9. DCC Plc.
  • 21.3.10. Swiss Precision Diagnostics GmbH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer